18-8783737-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001395333.1(MTCL1):āc.1705C>Gā(p.Leu569Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,610,254 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001395333.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTCL1 | NM_001395333.1 | c.1705C>G | p.Leu569Val | missense_variant | 5/15 | ENST00000695636.1 | NP_001382262.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTCL1 | ENST00000695636.1 | c.1705C>G | p.Leu569Val | missense_variant | 5/15 | NM_001395333.1 | ENSP00000512073.1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000167 AC: 4AN: 239352Hom.: 0 AF XY: 0.0000154 AC XY: 2AN XY: 130154
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1457996Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725054
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74444
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.625C>G (p.L209V) alteration is located in exon 6 (coding exon 4) of the MTCL1 gene. This alteration results from a C to G substitution at nucleotide position 625, causing the leucine (L) at amino acid position 209 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at